New Questions Around AI Clinical Records

• by Darius Tahir

• May 13, 2026

FDA Expands Afrezza to Pediatric Diabetes

The decision was supported by the phase 3 INHALE-1 trial and additional long-term safety, efficacy, and exposure data.

• by Kathryn Wighton

• May 29, 2026

• 3 min

Co-creating care: Involving children, young people, and families in paediatric medical device innovation

• by Jennifer Preston, Gemma Wheeler, Philippa Howsley, Jessica McNeill, Paul Dimitri

• May 25, 2026

Retinal Imaging AI May Flag Brain Health Risk

Authors said AI-driven retinal screening still lacks evidence that it improves patient outcomes.

• by Kerri Miller

• May 29, 2026

• 3 min